Product NDC: | 11534-134 |
Proprietary Name: | Senna and Docusate Sodium |
Non Proprietary Name: | Senna and Docusate Sodium |
Active Ingredient(s): | 50; 8.6 mg/1; mg/1 & nbsp; Senna and Docusate Sodium |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 11534-134 |
Labeler Name: | Sunrise Pharmaceutical Inc |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part334 |
Marketing Category: | OTC MONOGRAPH FINAL |
Start Marketing Date: | 20070726 |
Package NDC: | 11534-134-05 |
Package Description: | 57603 TABLET, FILM COATED in 1 CONTAINER, FLEXIBLE INTERMEDIATE BULK (11534-134-05) |
NDC Code | 11534-134-05 |
Proprietary Name | Senna and Docusate Sodium |
Package Description | 57603 TABLET, FILM COATED in 1 CONTAINER, FLEXIBLE INTERMEDIATE BULK (11534-134-05) |
Product NDC | 11534-134 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Senna and Docusate Sodium |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20070726 |
Marketing Category Name | OTC MONOGRAPH FINAL |
Labeler Name | Sunrise Pharmaceutical Inc |
Substance Name | DOCUSATE SODIUM; SENNOSIDES |
Strength Number | 50; 8.6 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes |